We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 105.00 | 100.00 | 110.00 | 105.00 | 105.00 | 105.00 | 26,109 | 07:33:18 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Investment Advice | 24k | -17.01M | -0.2722 | -3.86 | 65.59M |
From Apr 2019 to Apr 2024
TIDMMYT
RNS Number : 3008B
Mytrah Energy Ltd
05 October 2015
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN
5 October 2015
Mytrah Energy Limited
('Mytrah' or 'the Company')
Director Share Dealing
The Company was informed that on 2 October 2015, following a purchase of 7,000 Ordinary shares at 66.75 pence per share on the same day, Mr Rohit Phansalkar, a Non-Executive Director of the Company, has an interest in 7,000 Ordinary Shares, representing 0.004% of the issued share capital of the Company.
For further information please visit www.mytrah.com or contact:
Mytrah Energy Limited +44 (0)20 3402 Ravi Kailas / Bob Smith 5790 Investec Bank plc +44 (0)20 7597 Chris Sim / Jeremy Ellis 5970 Mirabaud Securities LLP +44 (0)20 7878 Peter Krens / Rory Scott 3360 Yellow Jersey PR Limited +44 (0)77 4778 Charles Goodwin / Dominic Barretto 8221
About Mytrah Energy Ltd. Mytrah Energy Ltd. (AIM: MYT), the pioneer and one of the largest Independent Power Producers ('IPP') in renewable energy, in India, with 560 MW of wind power generation across 11 projects and 6 States. The Company has 172 wind masts installed across multiple states in India, providing a rich source of information from which to select its future projects. Mytrah currently has an active development pipeline of about 3500 MW of wind and 500 MW of solar.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEAKESELKSFFF
(END) Dow Jones Newswires
October 05, 2015 12:49 ET (16:49 GMT)
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
